The clinical benefit of genome-wide cfDNA testing cannot be extrapolated from CVS data
Genet Med
.
2020 Mar;22(3):657-658.
doi: 10.1038/s41436-019-0689-5.
Epub 2019 Nov 6.
Authors
Erik A Sistermans
1
,
Diane Van Opstal
2
,
Mireille N Bekker
3
,
Mark D Pertile
4
5
Affiliations
1
Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
[email protected]
.
2
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
3
Department of Obstetrics and Gynaecology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
4
Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
5
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
PMID:
31690836
DOI:
10.1038/s41436-019-0689-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Cell-Free Nucleic Acids*
Female
Humans
Mosaicism
Placenta
Pregnancy
Prenatal Diagnosis
Substances
Cell-Free Nucleic Acids